Use of Tunnelled Catheters in Haematological Malignancy Patients with Neutropenia

This prospective study analysed 83 patients (age 45 ± 17 years) with haematological neoplasms, implanted with 93 tunnelled catheters, who were neutropenic or developed neutropenia during treatment. Catheters were implanted in the right (n = 82) or left (n = 11) jugular vein by the same surgical team...

Full description

Saved in:
Bibliographic Details
Published in:Journal of international medical research 2008-09, Vol.36 (5), p.1103-1111
Main Authors: Sariosmanoglu, N, Uğurlu, B, Turgut, NH, Demirkan, F, Ozsan, H, Ergor, G, Gulay, Z, Hazan, E, Oto, O
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Catheterization, Central Venous - adverse effects
Catheterization, Central Venous - instrumentation
Catheterization, Central Venous - utilization
Catheters, Indwelling - adverse effects
Catheters, Indwelling - utilization
Child
Child, Preschool
Device Removal
Female
Hematologic Neoplasms - complications
Humans
Infant
Infection - etiology
Jugular Veins - surgery
Male
Middle Aged
Neutropenia - etiology
Prospective Studies
Stem Cell Transplantation
Survival Rate
Citations: Items that this one cites
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This prospective study analysed 83 patients (age 45 ± 17 years) with haematological neoplasms, implanted with 93 tunnelled catheters, who were neutropenic or developed neutropenia during treatment. Catheters were implanted in the right (n = 82) or left (n = 11) jugular vein by the same surgical team using the same technique. They remained in place for 124 ± 88 days: 29% were removed due to infection; 18% due to treatment termination and 2% due to mechanical problems. Seventeen patients died with catheters in place. At 30, 60, 90, 120 and 200 days mean catheter duration rates were 82%, 75%, 65%, 60% and 35%, respectively, and freedom from catheter removal due to infection was 92%, 88%, 80%, 77% and 67%, respectively. Patient diagnosis and history of previous catheter infection did not increase catheter infection risk, but patients undergoing stem cell transplantation had an increased infection risk. Tunnelled catheters can be used in high-risk patients with neutropenia. Systemic infections can be managed in most patients without catheter removal.
ISSN:0300-0605
1473-2300
DOI:10.1177/147323000803600530